CollPlant Biotechnologies... (CLGN)
3.92
0.12 (3.16%)
At close: Jan 15, 2025, 1:12 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -7.02M | -16.93M | 237.00K | -5.77M | -11.16M | -3.69M | -6.01M | -7.25M | -4.78M | -3.34M | -4.73M | -4.60M |
| Depreciation & Amortization | 1.10M | 1.08M | 773.00K | 660.00K | 539.00K | 390.84K | 302.11K | 224.61K | 201.86K | 205.96K | 273.08K | 326.82K |
| Stock-Based Compensation | 1.94M | 2.17M | 1.60M | 1.67M | 1.13M | 1.37M | 1.43M | 928.61K | 1.05M | 52.65K | 132.66K | 489.57K |
| Other Working Capital | 93.00K | -592.00K | -761.00K | 36.00K | -344.00K | 2.24M | -252.33K | 542.30K | -375.29K | -34.16K | 388.51K | -99.84K |
| Other Non-Cash Items | 369.00K | 521.00K | -28.00K | 173.00K | 3.61M | -407.04K | 18.13K | 42.90K | -256.17 | -8.99K | -7.18K | -43.90K |
| Deferred Income Tax | n/a | n/a | -294.00K | -60.00K | -62.00K | 2.53 | n/a | n/a | -26.64K | -143.81K | 89.59K | 11.51K |
| Change in Working Capital | 848.00K | -544.00K | 216.00K | -1.12M | 247.00K | 1.09M | -888.19K | 1.02M | -156.52K | -89.11K | 438.19K | -47.65K |
| Operating Cash Flow | -2.76M | -13.70M | 2.50M | -4.45M | -5.70M | -1.24M | -5.15M | -5.04M | -3.71M | -3.33M | -3.80M | -3.86M |
| Capital Expenditures | -954.00K | -1.32M | -1.59M | -519.00K | -1.49M | -792.05K | -128.61K | -127.91K | -355.82K | -86.29K | -136.11K | -120.99K |
| Acquisitions | n/a | -30.20M | 33.00K | n/a | 30.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -20.00M | -30.00M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | 50.24M | -33.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -202.00K | 30.20M | 33.00K | -82.00K | 30.00K | -164.62K | n/a | n/a | n/a | -15.67K | 22.11K | -26.77K |
| Investing Cash Flow | -1.16M | 28.92M | -31.56M | -519.00K | -1.46M | -956.67K | -128.61K | -127.91K | -355.82K | -101.95K | -114.00K | -147.75K |
| Debt Repayment | n/a | n/a | n/a | -24.00K | -20.00K | 46.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.11M | 1.87M | 6.02M | 89.00K | -17.00K | -70.00K | 954.00K | -4.94K | 11.64K | 11.56K | 7.87M | n/a |
| Financial Cash Flow | 1.11M | 1.87M | 38.76M | 4.46M | 5.41M | 2.63M | 9.32M | 4.81M | 2.57M | 11.56K | 7.87M | 3.48M |
| Net Cash Flow | -3.19M | 16.49M | 9.85M | -445.00K | -1.69M | 596.89K | 4.03M | -395.15K | -1.47M | -3.27M | 3.87M | -501.88K |
| Free Cash Flow | -3.72M | -15.01M | 912.00K | -4.97M | -7.19M | -2.03M | -5.27M | -5.17M | -4.07M | -3.41M | -3.94M | -3.98M |